Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.

Nat Med

Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.

Published: January 2022

Download full-text PDF	Source
http://dx.doi.org/10.1038/s41591-021-01673-3	DOI Listing

Publication Analysis

publisher correction

correction toripalimab

toripalimab placebo

placebo chemotherapy

chemotherapy first-line

first-line treatment

treatment advanced

advanced nasopharyngeal

nasopharyngeal carcinoma

carcinoma multicenter

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!